CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer
Jan 25, 2020 - pubmed.gov
Cannabidiol (CBD) has emerged as a potential agent for breast cancer management. In this work, the potential use of cannabidiol in solution (CBDsol) and encapsulated in…
Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study
November 12, 2019 - pubmed.gov
Chronic pain is highly prevalent in most of the industrialized nations around the world. Despite the documented adverse effects, opioids are widely used for…
Dental plaque is a global health problem affecting people of various age groups. Cannabinoids are gaining enormous research attention due to its beneficial properties for…
Given the growing challenges in chronic pain management coupled with the ongoing consequences of the opioid epidemic , pain management practitioners are looking into more effective, innovative...
The proposed mechanisms of action of CBD in epilepsy
Jan 1, 2020 - pubmed.gov
Highly purified cannabidiol (CBD) (approved as Epidiolex® in the United States and as EPIDYOLEX from the EU agency) has demonstrated efficacy with an acceptable safety profile in patients with Lennox-Gastaut…
Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings
Aug 28, 2019 - pubmed.gov
Cannabis sativa (cannabis) is one of the oldest plants cultivated by men. Cannabidiol (CBD) is the major non-psychomimetic compound derived from cannabis. It has been proposed to have…
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Apr 1 , 2015 - pubmed.gov
First isolated from Cannabis in 1940 by Roger Adams, the structure of CBD was not completely elucidated until 1963. Subsequent studies resulted in the pronouncement that THC was…
English
Chinese (Simplified)
Dutch
French
German
Hindi
Italian
Lithuanian
Norwegian
Polish
Russian
Spanish
Swedish